| 1 |
31479512 | Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients. | 2020 Jun 1 |
1 |
| 2 |
29861877 | SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand. | 2018 May 18 |
1 |
| 3 |
27737534 | ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer. | 2017 Jul |
1 |
| 4 |
26950035 | MRP1 expression in CTCs confers resistance to irinotecan-based chemotherapy in metastatic colorectal cancer. | 2016 Aug 15 |
1 |
| 5 |
26125934 | Correlation of UGT1A1 and ERCC1 gene polymorphisms with the outcome of combined irinotecan plus cisplatin treatment in recurrent ovarian cancer. | 2015 Jun 29 |
3 |
| 6 |
25083297 | Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy. | 2014 Aug |
2 |
| 7 |
24548447 | [Clinical values of detecting excision repair cross complementing 1 and top-isomerase I in individualized therapies of metastatic colorectal cancer]. | 2013 Dec 24 |
1 |
| 8 |
17905465 | ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer. | 2008 Mar |
1 |
| 9 |
18231104 | Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. | 2008 Feb 26 |
1 |
| 10 |
17390039 | Sensitivity to CPT-11 and platinum derivatives of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses. | 2007 May |
1 |
| 11 |
17549342 | Sensitivity to CPT-11 and platinum derivatives of stage I/II node-negative breast, lung, and gastric cancer with occult neoplastic cells in lymph node sinuses. | 2007 Jul |
1 |
| 12 |
16894565 | Molecular determinants of irinotecan efficacy. | 2006 Nov 15 |
2 |